These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 17609434
1. Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor. Grisouard J, Medunjanin S, Hermani A, Shukla A, Mayer D. Mol Endocrinol; 2007 Oct; 21(10):2427-39. PubMed ID: 17609434 [Abstract] [Full Text] [Related]
2. Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the regulation of receptor activity. Medunjanin S, Hermani A, De Servi B, Grisouard J, Rincke G, Mayer D. J Biol Chem; 2005 Sep 23; 280(38):33006-14. PubMed ID: 16076840 [Abstract] [Full Text] [Related]
3. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner. Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D. Cell Signal; 2013 Jun 23; 25(6):1395-402. PubMed ID: 23499909 [Abstract] [Full Text] [Related]
4. Akt stabilizes estrogen receptor alpha with the concomitant reduction in its transcriptional activity. Park S, Song J, Joe CO, Shin I. Cell Signal; 2008 Jul 23; 20(7):1368-74. PubMed ID: 18450422 [Abstract] [Full Text] [Related]
5. Glycogen synthase kinase 3beta phosphorylates p21WAF1/CIP1 for proteasomal degradation after UV irradiation. Lee JY, Yu SJ, Park YG, Kim J, Sohn J. Mol Cell Biol; 2007 Apr 23; 27(8):3187-98. PubMed ID: 17283049 [Abstract] [Full Text] [Related]
6. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha. Fan M, Park A, Nephew KP. Mol Endocrinol; 2005 Dec 23; 19(12):2901-14. PubMed ID: 16037132 [Abstract] [Full Text] [Related]
7. Janus kinase 2--a novel negative regulator of estrogen receptor α function. Gupta N, Grebhardt S, Mayer D. Cell Signal; 2012 Jan 23; 24(1):151-61. PubMed ID: 21907792 [Abstract] [Full Text] [Related]
8. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer. Liao X, Thrasher JB, Holzbeierlein J, Stanley S, Li B. Endocrinology; 2004 Jun 23; 145(6):2941-9. PubMed ID: 14988390 [Abstract] [Full Text] [Related]
9. ERalpha signaling through slug regulates E-cadherin and EMT. Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Shetuni B, Barsky SH. Oncogene; 2010 Mar 11; 29(10):1451-62. PubMed ID: 20101232 [Abstract] [Full Text] [Related]
10. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells. Marsaud V, Gougelet A, Maillard S, Renoir JM. Mol Endocrinol; 2003 Oct 11; 17(10):2013-27. PubMed ID: 12855746 [Abstract] [Full Text] [Related]
11. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity. Peterson TJ, Karmakar S, Pace MC, Gao T, Smith CL. Mol Cell Biol; 2007 Sep 11; 27(17):5933-48. PubMed ID: 17591692 [Abstract] [Full Text] [Related]
12. Protein kinase A activation of estrogen receptor alpha transcription does not require proteasome activity and protects the receptor from ligand-mediated degradation. Tsai HW, Katzenellenbogen JA, Katzenellenbogen BS, Shupnik MA. Endocrinology; 2004 Jun 11; 145(6):2730-8. PubMed ID: 15033909 [Abstract] [Full Text] [Related]
13. Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity. La Rosa P, Pesiri V, Leclercq G, Marino M, Acconcia F. Mol Endocrinol; 2012 May 11; 26(5):762-74. PubMed ID: 22446104 [Abstract] [Full Text] [Related]
14. Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation. Neumann M, Klar S, Wilisch-Neumann A, Hollenbach E, Kavuri S, Leverkus M, Kandolf R, Brunner-Weinzierl MC, Klingel K. Oncogene; 2011 May 26; 30(21):2485-92. PubMed ID: 21217772 [Abstract] [Full Text] [Related]
15. Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner. Flügel D, Görlach A, Michiels C, Kietzmann T. Mol Cell Biol; 2007 May 26; 27(9):3253-65. PubMed ID: 17325032 [Abstract] [Full Text] [Related]
16. Inhibiting proteasomal proteolysis sustains estrogen receptor-alpha activation. Fan M, Nakshatri H, Nephew KP. Mol Endocrinol; 2004 Nov 26; 18(11):2603-15. PubMed ID: 15284335 [Abstract] [Full Text] [Related]
17. Combination of PPT with LiCl Treatment Prevented Bilateral Ovariectomy-Induced Hippocampal-Dependent Cognition Deficit in Rats. Qu N, Zhou XY, Han L, Wang L, Xu JX, Zhang T, Chu J, Chen Q, Wang JZ, Zhang Q, Tian Q. Mol Neurobiol; 2016 Mar 26; 53(2):894-904. PubMed ID: 25535091 [Abstract] [Full Text] [Related]
18. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M. Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749 [Abstract] [Full Text] [Related]
19. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src. Liu H, Qiu J, Li N, Chen T, Cao X. J Biol Chem; 2010 Jul 16; 285(29):21934-42. PubMed ID: 20460377 [Abstract] [Full Text] [Related]